
HealthCap's Cortendo announces US listing
Swedish pharmaceutical company Cortendo, backed by life sciences VC HealthCap, is hoping to list on New York’s Nasdaq stock exchange.
The company has filed a registration statement with the US Securities and Exchange Commission, with the intention to float under the ticker symbol "SBBP".
No date or approximate timeline for the Nasdaq listing was publicised, and the company is yet to set a price range or the number of shares to be made available in the IPO.
After Cortendo raised $11m in October last year, HealthCap held 11.7% of the company's shares and votes; Swedish pension fund AP3 meanwhile held 9.4%, Storebrand 9.8% and Arctic Fund Management 2.2%. Before the private placement, Cortendo had been considering a listing on Oslo's Acxess stock exchange, but abandoned the listing after the investment round.
The company raised $27.5m in January 2015, when RA Capital, NEA and Broadfin Capital participated in a second private placement, alongside HealthCap.
Bank of America Merrill Lynch and Stifel will act as joint bookrunners for Cortendo's proposed offering, while JMP Securities will act as lead manager. Roth Capital Partners is co-manager and Arctic Securities is acting as an adviser to Cortendo.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater